title: RNA sequencing data from the placebo group of the Patient-derived Xenograft (PDX18) developed from a TFHL human biopsy.
design: Patient-derived xenograft (PDX) models were developed from TFHL human biopsies. These PDX models were divided into two groups: a placebo group and a 5-azacytidine-treated group. Protein-coding RNA sequencing was performed on these groups using the Illumina NextSeq 500 platform.
identifiers.namespace: SUB15202479
identifiers.id: PDX18_CT_Rep2